# Study of MB07811 in Subjects With Hypercholesterolemia

> **NCT00879112** · PHASE2 · WITHDRAWN · sponsor: **Ligand Pharmaceuticals** · enrollment: 80 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** MB07811
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00879112
- **Lead sponsor:** Ligand Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-04
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** Study terminated prior to initiation
- **Last updated:** 2011-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879112, "Study of MB07811 in Subjects With Hypercholesterolemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00879112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*